Statistics for Ombitasvir/paritaprevir/ritonavir/dasabuvir +/- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America
Total visits
| views | |
|---|---|
| Ombitasvir/paritaprevir/ritonavir/dasabuvir +/- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America | 128 |
Total visits per month
| views | |
|---|---|
| October 2023 | 0 |
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
File Visits
| views | |
|---|---|
| Ombitasvir-paritaprevir-ritonavir-dasabuvir -- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.pdf | 11 |
Top country views
| views | |
|---|---|
| United States | 52 |
| Chile | 35 |
| Germany | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 30 |
| Louisville | 7 |
| Alameda | 6 |
| Concepcion | 5 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |